
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GRAF CRISPR/Cas9 KO Plasmid (h) | sc-403652 | 20 µg | $397.00 |
ARHGAP26 encodes GRAF, a Rho GTPase-activating protein that downregulates Rho family signaling to coordinate actin cytoskeleton remodeling, membrane trafficking, and cell shape changes. Through its GAP activity and interactions with endocytic and cytoskeletal regulators, GRAF links Rho-dependent pathways to clathrin-mediated endocytosis and adhesion dynamics, influencing cell migration and polarity. Altered ARHGAP26 function has been associated with dysregulated cytoskeletal control in cancer-related processes and is also implicated in hematologic malignancies through recurrent gene rearrangements, supporting investigation of its role in signaling rewiring and cellular transformation.
GRAF CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ARHGAP26 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the ARHGAP26 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the ARHGAP26 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish GRAF protein expression.
This CRISPR knockout system enables efficient generation of ARHGAP26-deficient cell models for investigation of GRAF signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.